title: Incretins and risk of neoplasia.
authors.affiliation: Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ 85259, USA. thorvardur.halfdanarson@mayo.edu
authors.forename: Thorvardur R
authors.initials: TR
authors.lastname: Halfdanarson
authors.forename: Rahul
authors.initials: R
authors.lastname: Pannala
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects; D054795:Incretins / Q000008:administration & dosage / Q000009:adverse effects*; D010190:Pancreatic Neoplasms / Q000139:chemically induced* / Q000517:prevention & control; D011358:Product Surveillance, Postmarketing; D018570:Risk Assessment / Q000379:methods / Q000706:statistics & numerical data
chemical_list: D007004:Hypoglycemic Agents; D054795:Incretins